Edition:
United States

Kazia Therapeutics Ltd (KZIA.OQ)

KZIA.OQ on NASDAQ Stock Exchange Capital Market

2.58USD
1:47pm EST
Change (% chg)

$0.28 (+12.17%)
Prev Close
$2.30
Open
$2.31
Day's High
$2.58
Day's Low
$2.28
Volume
2,924
Avg. Vol
1,126
52-wk High
$7.56
52-wk Low
$2.28

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 0.11 -0.013
Dec 0.14 -0.037
FY 2016 Jun '16 0.24 -0.077
Dec 0.17 -0.036
FY 2015 Jun '15 0.08 -0.065
Dec 0.01 -0.051
 
*Note: Units in Millions ofAustralian Dollars
**Note: Units in Australian Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Jun-17 1 0.14 0.14 0.14 --
Year Ending Jun-18 1 7.35 7.35 7.35 0.00
Year Ending Jun-19 1 17.31 17.31 17.31 0.00
Earnings (per share)
Year Ending Jun-17 1 -12.00 -12.00 -12.00 --
Year Ending Jun-18 1 -351.27 -351.27 -351.27 -16.00
Year Ending Jun-19 1 -219.23 -219.23 -219.23 -24.00
Sales and Profit Figures in Australian Dollar (AUD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 196.13 36.03
P/E High - Last 5 Yrs. -- 279.92 45.26
P/E Low - Last 5 Yrs. -- 93.48 24.26
Beta 0.49 0.82 0.91
Price to Sales (TTM) 67.72 117.54 5.90
Price to Book (MRQ) 1.49 23.08 5.74
Price to Tangible Book (MRQ) 1.79 26.92 7.33
Price to Cash Flow (TTM) -- 106.51 24.72
% Owned Institutions 1.60 5.59 1.38

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.48
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 2.02 5.23
Payout Ratio(TTM) -- 98.85 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -55.57 -4.33 6.77
Sales (TTM) vs TTM 1 Yr. Ago -38.66 30.49 5.56
Sales - 5 Yr. Growth Rate -29.68 33.28 10.25
EPS (MRQ) vs Qtr. 1 Yr. Ago 82.47 -148.85 7.88
EPS (TTM) vs TTM 1 Yr. Ago 55.28 -- --
EPS - 5 Yr. Growth Rate -- 44.44 10.92
Capital Spending - 5 Yr. Growth Rate 63.40 41.25 15.15

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.81 2.55
Current Ratio (MRQ) 3.62 5.63 3.57
LT Debt to Equity (MRQ) 0.00 16.33 13.26
Total Debt to Equity (MRQ) 0.00 18.85 19.22
Interest Coverage (TTM) -381,217.00 -144.78 43.79

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 43.82 54.87
Gross Margin - 5 Yr. Avg. -- 55.59 52.44
EBITD Margin (TTM) -6,924.99 -- --
EBITD - 5 Yr. Avg -2,506.94 -215.54 15.70
Operating Margin (TTM) -7,495.51 -635.70 6.77
Operating Margin - 5 Yr. Avg. -2,718.78 -232.57 11.08
Pre-Tax Margin (TTM) -4,367.83 -605.50 7.60
Pre-Tax Margin - 5 Yr. Avg. -2,028.72 -232.71 11.49
Net Profit Margin (TTM) -4,288.05 -603.22 3.83
Net Profit Margin - 5 Yr. Avg. -2,018.50 -236.06 7.78
Effective Tax Rate (TTM) -- 15.54 24.27
Effective Tax Rate - 5 Yr. Avg. -- 19.17 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,216,302 857,902,259
Net Income/Employee (TTM) -- -2,116,531 100,310,105
Receivable Turnover (TTM) 0.11 26.19 6.13
Inventory Turnover (TTM) -- 2.65 3.55
Asset Turnover (TTM) 0.01 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -29.88 -9.39 11.35
Return on Assets - 5 Yr. Avg. -34.24 0.13 12.32
Return on Investment (TTM) -33.03 -11.69 14.48
Return on Investment - 5 Yr. Avg. -38.70 3.37 16.13
Return on Equity (TTM) -36.01 -36.44 16.06
Return on Equity - 5 Yr. Avg. -39.42 5.73 17.32
  1 Year 3 Year 5 Year
Sales % -38.66 42.12 -29.68
EPS (TTM) % 79.79 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Kazia Therapeutics Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 1.60%
# of Holders: 5
Total Shares Held: 77,316
3 Mo. Net Change: 320
# New Positions: 0
# Closed Positions: 2
# Increased Positions: 3
# Reduced Positions: 2
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.